{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:24:18Z","timestamp":1791923058968,"version":"4.3.4"},"reference-count":76,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Metabolic reprogramming and epigenetic alterations contribute to the aggressiveness of human bladder cancer (BC). Lactate-dependent histone modification represents a novel class of histone marks that links the glycolytic metabolite to the epigenetic mechanism of lactylation. However, the role of histone lactylation in BC remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>\n                      The single-cell RNA sequencing dataset GSE135337 was analyzed to assess glycolysis and histone lactylation levels in BC samples. Subsequently, western blotting and immunofluorescence analyses were employed to detect the levels of histone lactylation in BC. The inhibition of histone lactylation, achieved via glycolysis inhibitors or lactate dehydrogenase A (LDHA) knockdown, was confirmed to impede BC growth and progression in both\n                      <jats:italic>in vitro<\/jats:italic>\n                      and\n                      <jats:italic>in vivo<\/jats:italic>\n                      studies. Potential target genes of H3K18 lactylation (H3K18la) were screened through CUT&amp;amp;Tag and RNA-seq analyses.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The study identified a notable increase in glycolytic activity and histone lactylation, especially H3K18la, which correlated with poor prognosis in BC patients. Inhibiting glycolytic activity through various inhibitors or LDHA knockdown led to anti-tumor effects in BC in both\n                      <jats:italic>in vitro<\/jats:italic>\n                      and\n                      <jats:italic>in vivo<\/jats:italic>\n                      studies. CUT&amp;amp;Tag of H3K18la combined with RNA-seq analysis identified four potential target genes (AHNAK2, PVR, SLC7A11, and SREBF1). These genes were found to be associated with the growth and invasion of BC potentially through complex metabolic regulatory mechanisms within the tumor microenvironment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Glycolysis closely linked to H3K18la enrichment at the AHNAK2, PVR, SLC7A11, and SREBF1 loci, established a correlative epigenetic network that accompanies aggressive BC progression. These findings reveal important connections between lactate metabolism reprogramming and epigenetic regulation, potentially leading to new therapeutic strategies targeting lactylation in BC treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1777092","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T05:37:41Z","timestamp":1782797861000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Glycolysis-mediated H3K18la modifications drive aggressive bladder cancer through metabolic and epigenetic reprogramming"],"prefix":"10.3389","volume":"17","author":[{"given":"Zhan","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, China"]},{"name":"Department of Urology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaokai","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Xiangya Hospital of Central South University","place":["Changsha, Hunan, China"]},{"name":"National Clinical Research Center for Metabolic Diseases, The Second Xiangya Hospital of Central South University","place":["Changsha, Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pediatric Urology, Guangzhou Medical University Affiliated Women and Children\u2019s Medical Center","place":["Guangzhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozu","family":"Li","sequence":"additional","affiliation":[{"name":"The First Clinical College of Zhengzhou University, Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingchen","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Xinyang Central Hospital","place":["Xinyang, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyang","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Xiangya Hospital of Central South University","place":["Changsha, Hunan, China"]},{"name":"National Clinical Research Center for Metabolic Diseases, The Second Xiangya Hospital of Central South University","place":["Changsha, Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Xiangya Hospital of Central South University","place":["Changsha, Hunan, China"]},{"name":"National Clinical Research Center for Metabolic Diseases, The Second Xiangya Hospital of Central South University","place":["Changsha, Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, The First Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Xing","sequence":"additional","affiliation":[{"name":"Department of Emergency Intensive Care Unit (ICU), The First Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(22)01188-6","article-title":"Current best practice for bladder cancer: a narrative review of diagnostics and treatments","volume":"400","author":"Comp\u00e9rat","year":"2022","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"10482","DOI":"10.1038\/s41598-024-61302-0","article-title":"Predicting bladder cancer survival with high accuracy: insights from MAPK pathway-related genes","volume":"14","author":"Cheng","year":"2024","journal-title":"Sci Rep"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.13785","article-title":"Low visceral adipose tissue predicts the outcome of neoadjuvant chemotherapy for colorectal liver metastases: a multicentre real-world study","volume":"16","author":"Chen","year":"2025","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2423043","article-title":"KRAS mutations promote the intratumoral colonization of enterotoxigenic bacteroides fragilis in colorectal cancer through the regulation of the miRNA3655\/SURF6\/IRF7\/IFN\u03b2 axis","volume":"16","author":"Chen","year":"2024","journal-title":"Gut Microbes"},{"key":"B5","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1039\/d2mo00220e","article-title":"Focus on the molecular mechanisms of cisplatin resistance based on multi-omics approaches","volume":"19","author":"Yue","year":"2023","journal-title":"Mol Omics"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.3390\/cancers16071418","article-title":"Cisplatin-resistant urothelial bladder cancer cells undergo metabolic reprogramming beyond the Warburg effect","volume":"16","author":"Afonso","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","article-title":"Bladder cancer","volume":"9","author":"Dyrskj\u00f8t","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15047","article-title":"The Warburg effect as a therapeutic target for bladder cancers and intratumoral heterogeneity in associated molecular targets","volume":"112","author":"Burns","year":"2021","journal-title":"Cancer Sci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100938","article-title":"Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms","volume":"68","author":"Li","year":"2023","journal-title":"Drug Resist Update"},{"key":"B10","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12943-023-01856-1","article-title":"CircXRN2 suppresses tumor progression driven by histone lactylation through activating the Hippo pathway in human bladder cancer","volume":"22","author":"Xie","year":"2023","journal-title":"Mol Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.tig.2021.09.009","article-title":"Histone lactylation: epigenetic mark of glycolytic switch","volume":"38","author":"Dai","year":"2022","journal-title":"Trends Genet"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.34133\/research.0549","article-title":"PRMT5-mediated ALKBH5 methylation promotes colorectal cancer immune evasion via increasing CD276 expression","volume":"8","author":"Meng","year":"2025","journal-title":"Res (Wash D C)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101059","article-title":"Single-cell transcriptome analysis reveals the association between histone lactylation and cisplatin resistance in bladder cancer","volume":"73","author":"Li","year":"2024","journal-title":"Drug Resist Update"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.molcel.2022.02.033","article-title":"Lactylation-driven METTL3-mediated RNA m(6)A modification promotes immunosuppression of tumor-infiltrating myeloid cells","volume":"82","author":"Xiong","year":"2022","journal-title":"Mol Cell"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.34133\/research.0182","article-title":"Cold-induced reprogramming of subcutaneous white adipose tissue assessed by single-cell and single-nucleus RNA sequencing","volume":"6","author":"Liu","year":"2023","journal-title":"Res (Wash D C)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33794","article-title":"Single-cell RNA sequencing reveals the epithelial cell heterogeneity and invasive subpopulation in human bladder cancer","volume":"149","author":"Lai","year":"2021","journal-title":"Int J Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1186\/1755-8794-3-21","article-title":"SEURAT: visual analytics for the integrated analysis of microarray data","volume":"3","author":"Gribov","year":"2010","journal-title":"BMC Med Genomics"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.4314","article-title":"Dimensionality reduction for visualizing single-cell data using UMAP","author":"Becht","year":"2018","journal-title":"Nat Biotechnol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1186\/s12967-022-03795-9","article-title":"Smooth muscle cell fate decisions decipher a high-resolution heterogeneity within atherosclerosis molecular subtypes","volume":"20","author":"Zhang","year":"2022","journal-title":"J Transl Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"5077","DOI":"10.1038\/s41467-020-18916-5","article-title":"Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma","volume":"11","author":"Chen","year":"2020","journal-title":"Nat Commun"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.ccell.2022.11.005","article-title":"Interferon-dependent SLC14A1(+) cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancer","volume":"40","author":"Ma","year":"2022","journal-title":"Cancer Cell"},{"key":"B22","doi-asserted-by":"publisher","first-page":"6740","DOI":"10.1038\/s41467-022-34495-z","article-title":"Single cell sequencing reveals that CD39 inhibition mediates changes to the tumor microenvironment","volume":"13","author":"Liu","year":"2022","journal-title":"Nat Commun"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and analysis of cell-cell communication using CellChat","volume":"12","author":"Jin","year":"2021","journal-title":"Nat Commun"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.34133\/research.0522","article-title":"eMCI: An explainable multimodal correlation integration model for unveiling spatial transcriptomics and intercellular signaling","volume":"7","author":"Hong","year":"2024","journal-title":"Res (Wash D C)"},{"key":"B25","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12967-024-04955-9","article-title":"A multi-dimensional approach to unravel the intricacies of lactylation related signature for prognostic and therapeutic insight in colorectal cancer","volume":"22","author":"Huang","year":"2024","journal-title":"J Transl Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.2147\/jir.S414452","article-title":"Identification and analysis of neutrophil extracellular trap-related genes in osteoarthritis by bioinformatics and experimental verification","volume":"16","author":"Luan","year":"2023","journal-title":"J Inflammation Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1162458","article-title":"Unveiling the key genes, environmental toxins, and drug exposures in modulating the severity of ulcerative colitis: a comprehensive analysis","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2019040335","article-title":"Single-cell transcriptomic map of the human and mouse bladders","volume":"30","author":"Yu","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.immuni.2020.05.010","article-title":"Single-cell RNA-seq mapping of human thymopoiesis reveals lineage specification trajectories and a commitment spectrum in T cell development","volume":"52","author":"Le","year":"2020","journal-title":"Immunity"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111606","article-title":"Single-cell transcriptome profiling and chromatin accessibility reveal an exhausted regulatory CD4+ T cell subset in systemic lupus erythematosus","volume":"41","author":"Guo","year":"2022","journal-title":"Cell Rep"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2022.10.009","article-title":"Targeting lactate-related cell cycle activities for cancer therapy","volume":"86","author":"Lin","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011371","article-title":"Senecavirus A-induced glycolysis facilitates virus replication by promoting lactate production that attenuates the interaction between MAVS and RIG-I","volume":"19","author":"Li","year":"2023","journal-title":"PloS Pathog"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/551S33a","article-title":"Bladder cancer","volume":"551","author":"Grayson","year":"2017","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2022.01.007","article-title":"The hallmarks of cancer metabolism: Still emerging","volume":"34","author":"Pavlova","year":"2022","journal-title":"Cell Metab"},{"key":"B35","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.apsb.2023.12.003","article-title":"Targeting the Warburg effect: a revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer","volume":"14","author":"Liao","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166769","article-title":"Regulating mitochondrial metabolism by targeting pyruvate dehydrogenase with dichloroacetate, a metabolic messenger","volume":"1869","author":"Schoenmann","year":"2023","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B37","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3390\/ijms21010234","article-title":"2-Deoxy-d-glucose and its analogs: from diagnostic to therapeutic agents","volume":"21","author":"Pajak","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-021-00378-6","article-title":"Cancer metabolism: looking forward","volume":"21","author":"Mart\u00ednez-Reyes","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2022.09.007","article-title":"Tumor glycolysis, an essential sweet tooth of tumor cells","volume":"86","author":"Paul","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13046-024-03042-7","article-title":"Pan-cancer analysis implicates novel insights of lactate metabolism into immunotherapy response prediction and survival prognostication","volume":"43","author":"Chen","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.32332","article-title":"A CRISPR interference of CBP and p300 selectively induced synthetic lethality in bladder cancer cells in vitro","volume":"15","author":"Li","year":"2019","journal-title":"Int J Biol Sci"},{"key":"B42","doi-asserted-by":"publisher","first-page":"a026831","DOI":"10.1101\/cshperspect.a026831","article-title":"HDACs and HDAC inhibitors in cancer development and therapy","volume":"6","author":"Li","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"15119","DOI":"10.3390\/ijms232315119","article-title":"Sirtuins (SIRTs) as a novel target in gastric cancer","volume":"23","author":"Poniewierska-Baran","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B44","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s13238-021-00846-7","article-title":"Metabolic reprogramming and epigenetic modifications on the path to cancer","volume":"13","author":"Sun","year":"2022","journal-title":"Protein Cell"},{"key":"B45","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.cmet.2023.12.023","article-title":"Augmentation of scleral glycolysis promotes myopia through histone lactylation","volume":"36","author":"Lin","year":"2024","journal-title":"Cell Metab"},{"key":"B46","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12943-024-02008-9","article-title":"Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma","volume":"23","author":"Li","year":"2024","journal-title":"Mol Cancer"},{"key":"B47","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s43556-025-00275-6","article-title":"Histone and non-histone lactylation: molecular mechanisms, biological functions, diseases, and therapeutic targets","volume":"6","author":"Peng","year":"2025","journal-title":"Mol BioMed"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.21147\/j.issn.1000-9604.2025.06.13","article-title":"Curcumol overcomes cisplatin resistance and rewires glycolysis-H3K9la-ORC6 axis to trigger ferroptosis in bladder cancer","volume":"37","author":"Zhang","year":"2025","journal-title":"Chin J Cancer Res"},{"key":"B49","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12943-025-02295-w","article-title":"Lactate accumulation induces H4K12la to activate super-enhancer-driven RAD23A expression and promote niraparib resistance in ovarian cancer","volume":"24","author":"Lu","year":"2025","journal-title":"Mol Cancer"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-025-03669-6","article-title":"An H4K12la\/CEBPB-AKR1C2 signaling axis modulates the mTOR pathway to regulate cisplatin resistance in lung cancer","volume":"45","author":"Wang","year":"2026","journal-title":"Oncogene"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.7150\/thno.18198","article-title":"AHNAK2 is a novel prognostic marker and oncogenic protein for clear cell renal cell carcinoma","volume":"7","author":"Wang","year":"2017","journal-title":"Theranostics"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107185","article-title":"AHNAK2 is a novel prognostic marker and correlates with immune infiltration in papillary thyroid cancer: Evidence from integrated analysis","volume":"90","author":"Zheng","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e33687","article-title":"Identification of gemcitabine resistance-related AHNAK2 gene associated with prognosis and immune infiltration in pancreatic cancer","volume":"10","author":"Ou","year":"2024","journal-title":"Heliyon"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107134","article-title":"Correlation between prognostic indicator AHNAK2 and immune infiltrates in lung adenocarcinoma","volume":"90","author":"Zheng","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1258951","article-title":"AHNAKs roles in physiology and Malignant tumors","volume":"13","author":"Zhang","year":"2023","journal-title":"Front Oncol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.01187","article-title":"Identification of microenvironment-related prognostic genes in bladder cancer based on gene expression profile","volume":"10","author":"Luo","year":"2019","journal-title":"Front Genet"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.815290","article-title":"Pyroptosis-related patterns predict tumor immune landscape and immunotherapy response in bladder cancer","volume":"9","author":"Yan","year":"2022","journal-title":"Front Mol Biosci"},{"key":"B58","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.cytogfr.2020.05.004","article-title":"Intracellular partners of fibroblast growth factors 1 and 2 - implications for functions","volume":"57","author":"Sluzalska","year":"2021","journal-title":"Cytokine Growth Factor Rev"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.3390\/cancers13081748","article-title":"Prognostic impact of AHNAK2 expression in patients treated with radical cystectomy","volume":"13","author":"Koguchi","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1177\/1533033820980088","article-title":"CD155-prognostic and immunotherapeutic implications based on multiple analyses of databases across 33 human cancers","volume":"20","author":"Zhang","year":"2021","journal-title":"Technol Cancer Res Treat"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2019.07.006","article-title":"Poliovirus receptor CD155 is up-regulated in muscle-invasive bladder cancer and predicts poor prognosis","volume":"38","author":"Zhang","year":"2020","journal-title":"Urol Oncol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.660273","article-title":"A poliovirus receptor (CD155)-related risk signature predicts the prognosis of bladder cancer","volume":"11","author":"Luo","year":"2021","journal-title":"Front Oncol"},{"key":"B63","article-title":"SLC7A11\/xCT in cancer: biological functions and therapeutic implications","volume":"10","author":"Lin","year":"2020","journal-title":"Am J Cancer Res"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.74546","article-title":"PHGDH inhibits ferroptosis and promotes Malignant progression by upregulating SLC7A11 in bladder cancer","volume":"18","author":"Shen","year":"2022","journal-title":"Int J Biol Sci"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202403995","article-title":"Deubiquitylase USP52 promotes bladder cancer progression by modulating ferroptosis through stabilizing SLC7A11\/xCT","volume":"11","author":"Liu","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"B66","doi-asserted-by":"publisher","first-page":"5144","DOI":"10.3390\/ijms24065144","article-title":"HSPA5 promotes the proliferation, metastasis and regulates ferroptosis of bladder cancer","volume":"24","author":"Wang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.labinv.2022.100058","article-title":"p53 activates the lipoxygenase activity of ALOX15B via inhibiting SLC7A11 to induce ferroptosis in bladder cancer cells","volume":"103","author":"Li","year":"2023","journal-title":"Lab Invest"},{"key":"B68","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1186\/s12935-024-03570-4","article-title":"IMP2 drives chemoresistance by repressing cisplatin-induced apoptosis and ferroptosis via activation of IPO4 and SLC7A11 under hypoxia in bladder cancer","volume":"24","author":"Yan","year":"2024","journal-title":"Cancer Cell Int"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1158\/1078-0432.Ccr-13-2805","article-title":"Reduced expression of miRNA-27a modulates cisplatin resistance in bladder cancer by targeting the cystine\/glutamate exchanger SLC7A11","volume":"20","author":"Drayton","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.836939","article-title":"Fatty acid synthase is the key regulator of fatty acid metabolism and is related to immunotherapy in bladder cancer","volume":"13","author":"Xiong","year":"2022","journal-title":"Front Immunol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.7150\/thno.28219","article-title":"Adipocytes fuel gastric cancer omental metastasis via PITPNC1-mediated fatty acid metabolic reprogramming","volume":"8","author":"Tan","year":"2018","journal-title":"Theranostics"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-12-1329","article-title":"FGFR3 stimulates stearoyl CoA desaturase 1 activity to promote bladder tumor growth","volume":"72","author":"Du","year":"2012","journal-title":"Cancer Res"},{"key":"B73","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41392-021-00493-8","article-title":"Metformin targets Clusterin to control lipogenesis and inhibit the growth of bladder cancer cells through SREBP-1c\/FASN axis","volume":"6","author":"Deng","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B74","doi-asserted-by":"publisher","first-page":"11943","DOI":"10.3390\/ijms231911943","article-title":"Lactate-lactylation hands between metabolic reprogramming and immunosuppression","volume":"23","author":"Chen","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B75","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13062-025-00650-x","article-title":"Integrating machine learning models with multi-omics analysis to decipher the prognostic significance of mitotic catastrophe heterogeneity in bladder cancer","volume":"20","author":"Dai","year":"2025","journal-title":"Biol Direct"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1572034","article-title":"Advancing personalized, predictive, and preventive medicine in bladder cancer: a multi-omics and machine learning approach for novel prognostic modeling, immune profiling, and therapeutic target discovery","volume":"16","author":"Yan","year":"2025","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1777092\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T05:37:42Z","timestamp":1782797862000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1777092\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":76,"alternative-id":["10.3389\/fimmu.2026.1777092"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1777092","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"article-number":"1777092"}}